Results 271 to 280 of about 752,420 (346)

AI in Neurology: Everything, Everywhere, All at Once Part 1: Principles and Practice

Annals of Neurology, EarlyView.
Artificial intelligence (AI) is rapidly transforming healthcare, yet it often remains opaque to clinicians, scientists, and patients alike. This review, part 1 of a 3‐part series, provides neurologists and neuroscientists with a foundational understanding of AI's key concepts, terminology, and applications.
Matthew Rizzo, Jeffrey D. Dawson
wiley   +1 more source

Steroidomic Changes in the Cerebrospinal Fluid of Women with Multiple Sclerosis. [PDF]

Int J Mol Sci
Kancheva R, Kubala Havrdová E, Velíková M, Kancheva L, Včelák J, Ampapa R, Židó M, Štětkářová I, Škodová T, Hill M.   +9 more
europepmc   +1 more source

FURTHER CONSIDERATIONS ON THE GEOGRAPHIC DISTRIBUTION OF MULTIPLE SCLEROSIS

, 1967
John F. Kurtzke
openalex   +1 more source

AI in Neurology: Everything, Everywhere, all at Once PART 2: Speech, Sentience, Scruples, and Service

Annals of Neurology, EarlyView.
Artificial intelligence (AI) applications are finding use in real‐world neurological settings. Whereas part 1 of this 3‐part review series focused on the birth of AI and its foundational principles, this part 2 review shifts gears to explore more practical aspects of neurological care.
Matthew Rizzo
wiley   +1 more source

Functional Mobility Assessment in People with Multiple Sclerosis. [PDF]

Neurol Int
Sretenović I, Potić S, Nedović G, Odović G, Šimpraga L.   +4 more
europepmc   +1 more source

Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort Study

Annals of Neurology, EarlyView.
Objective To compare clinical and radiological outcomes among relapsing multiple sclerosis patients treated with autologous hematopoietic stem cell transplantation (AHSCT), alemtuzumab (ATZ), and ocrelizumab (OCR). Methods From a London (UK) hospital‐based observational cohort, modeled data were obtained from 621 relapsing–remitting multiple sclerosis ...
Paolo Antonio Muraro, Antonio Zito, Alessio Signori, Maria Pia Sormani, Eleonora Rigoni, Federica Pollidoro, Roberto Bergamaschi, Alice Mariottini, Omar Malik, Ashwini Nandoskar, Victoria Singh‐Curry, Varun Mehra, Majid Kazmi, Ian Gabriel, Eli Silber, Richard Nicholas, Antonio Scalfari   +16 more
wiley   +1 more source

Cognitive reserve in multiple sclerosis: The role of depression and fatigue. [PDF]

Mult Scler
Stein C, O'Keeffe F, Brosnan M, Flynn C, McGuigan C, Bramham J.   +5 more
europepmc   +1 more source

Detecting New Lesions Using a Large Language Model: Applications in Real‐World Multiple Sclerosis Datasets

Annals of Neurology, EarlyView.
Objective Neuroimaging is routinely utilized to identify new inflammatory activity in multiple sclerosis (MS). A large language model to classify narrative magnetic resonance imaging reports in the electronic health record (EHR) as discrete data could provide significant benefits for MS research. The objectives of the current study were to develop such
Shane Poole, Nikki Sisodia, Kanishka Koshal, Kyra Henderson, Jaeleene Wijangco, Danelvis Paredes, Chelsea Chen, William Rowles, Amit Akula, Jens Wuerfel, Vishakha Sharma, UCSF Multiple Sclerosis and Neuroinflammation Center clinicians, Andreas M. Rauschecker, Roland G. Henry, Riley Bove   +14 more
wiley   +1 more source

Phosphatemia is an Independent Prognostic Factor in Amyotrophic Lateral Sclerosis

Annals of Neurology, EarlyView.
Objective The objective of this study was to evaluate the prognostic value of several muscle damage biomarkers. Methods Data from Piemonte and Valle d'Aosta Amyotrophic Lateral Sclerosis (PARALS) were considered for this study. Survival was defined as the time from diagnosis to death, tracheostomy, or the censoring date.
Rosario Vasta, Emanuele Koumantakis, Antonio Canosa, Umberto Manera, Maurizio Grassano, Francesca Palumbo, Sara Cabras, Enrico Matteoni, Francesca Di Pede, Filippo De Mattei, Filippo Vergnano, Jessica Mandrioli, Cecilia Simonini, Ilaria Martinelli, Fabiola De Marchi, Letizia Mazzini, Cristina Moglia, Andrea Calvo, Adriano Chiò   +18 more
wiley   +1 more source

Is DEXI a Multiple Sclerosis Susceptibility Gene? [PDF]

Int J Mol Sci
Eriksson AM, Emini N, Harbo HF, Berge T.
europepmc   +1 more source